SVB Leerink Downgrades WAVE Life Sciences to Market Perform, Lowers Price Target to $10

SVB Leerink analyst Mani Foroohar downgrades WAVE Life Sciences (NASDAQ:WVE) from Outperform to Market Perform and lowers the price target from $33 to $10.

Benzinga · 12/31/2019 12:14

SVB Leerink analyst Mani Foroohar downgrades WAVE Life Sciences (NASDAQ:WVE) from Outperform to Market Perform and lowers the price target from $33 to $10.